Clinical Trial Update: Transcranial Stimulation (tDCS) For the Treatment of Neuropathic Facial Pain [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating transcranial direct current stimulation (tDCS) for neuropathic facial pain has been terminated. The sponsor listed is Beth Israel Medic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facial Pain
• Neuropathic Pain

Snippet

Sponsor: Beth Israel Medical Center | Conditions: Facial Pain | Phase 2 | Status: TERMINATED